Vanguard Global Advisers’s IGC Pharma IGC Stock Holding History

Vanguard Global Advisers’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.07K	Hold	14,944	–	–	﹤0.01%	3571
2026 Q1	$3.93K	Buy	+14,944	New	+$4.15K	﹤0.01%	3576

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Vanguard Global Advisers's IGC Position: Q2 2026 in Review

Vanguard Global Advisers held its IGC Pharma (IGC) position steady in Q2 2026 at 14,944 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3571.

Vanguard Global Advisers first reported a position in IGC in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Vanguard Global Advisers held 14,944 shares of IGC Pharma worth $4.07K as of Q2 2026.
Vanguard Global Advisers left its IGC Pharma share count unchanged in Q2 2026.
IGC Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3571 holding.
Vanguard Global Advisers first reported a position in IGC Pharma in Q1 2026 and has held it in 2 quarters since.
36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.